Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Eiger Biopharma
(NQ:
EIGR
)
11.02
USD
-0.84 (-7.08%)
Official Closing Price
Updated: 6:03 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Eiger Biopharma
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Investors Snatch EIGR Even Cheaper Than Its Secondary Stock Offering
April 22, 2019
Looking back to 5 days ago, Eiger BioPharmaceuticals Inc (EIGR) priced a 4,500,000 share secondary stock offering at $11.00 per share. Buyers in that offering made a considerable investment into the...
Tags
Stocks
From
Market News Video
54 Biggest Movers From Thursday
April 21, 2019
Gainers Mustang Bio, Inc. (NASDAQ: MBIO) shares climbed 112.03 percent to close at $5.64 on Thursday following news the New ...
Tags
PAGS
MBRX
CENX
From
Benzinga
48 Stocks Moving In Thursday's Mid-Day Session
April 18, 2019
Gainers Mustang Bio, Inc. (NASDAQ: MBIO) shares jumped 135 percent to $6.25 following news the New England Journal of Medicine ...
Tags
News
TCBI
MAN
From
Benzinga
Eiger BioPharmaceuticals (EIGR) Shares Cross Below 200 DMA
April 18, 2019
In trading on Thursday, shares of Eiger BioPharmaceuticals Inc (EIGR) crossed below their 200 day moving average of $12.00, changing hands as low as $10.94 per share. Eiger BioPharmaceuticals Inc...
Tags
Stocks
From
Market News Video
Mid-Morning Market Update: Markets Mostly Lower; Honeywell Tops Q1 Estimates
April 18, 2019
Following the market opening Thursday, the Dow traded up 0.05 percent to 26461.62 while the NASDAQ declined 0.51 percent to 7,955.91. ...
Tags
News
Global
Benzinga
From
Benzinga
31 Stocks Moving In Thursday's Pre-Market Session
April 18, 2019
Gainers Mustang Bio, Inc. (NASDAQ: MBIO) shares rose 192.5 percent to $7.78 in pre-market trading following news the New England ...
Tags
ALQA
VNTR
Losers
From
Benzinga
The Daily Biotech Pulse: Hookipa To Debut, Mustang Bio Skyrockets, AngioDynamics Sheds Portfolio
April 18, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours: No biotech stocks hit 52-week highs on ...
Tags
Earnings
FBIO
AIMT
From
Benzinga
11 Stocks To Watch For April 18, 2019
April 17, 2019
Some of the stocks that may grab investor focus today are: Wall Street expects Honeywell International Inc. (NYSE: HON) to report ...
Tags
TEAM
ISRG
Stocks to Watch
From
Benzinga
Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock
April 17, 2019
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR) today announced the pricing of an underwritten public offering of 4,500,000 shares of its common stock at a price to the public of $11.00 per share. All of...
From
PR Newswire
Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock
April 17, 2019
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to be sold in the offering are to be...
From
PR Newswire
Eiger BioPharmaceuticals Appoints Market Access, Public Policy Expert, and Biotech Veteran Amit K. Sachdev to Board of Directors
April 15, 2019
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of therapies for serious rare and ultra-rare diseases, announced today the appointment of Amit K....
From
PR Newswire
The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug
April 12, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
Earnings
VIVE
EDAP
From
Benzinga
Eiger Announces 36% Durable Virologic Response at 24 Weeks Post-Treatment with Peginterferon Lambda in Phase 2 LIMT HDV Study at The International Liver Congress™ 2019
April 11, 2019
- Improved Tolerability in HDV-infected Patients vs Historical Peginterferon Alfa
From
PR Newswire
The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug
April 11, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
VKTX
MRK
XBI
From
Benzinga
Research Report Identifies Aerojet Rocketdyne, Knight-Swift Transportation, Potbelly, Aqua Metals, OrthoPediatrics, and Eiger BioPharmaceuticals with Renewed Outlook — Fundamental Analysis, Calculatin
April 08, 2019
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Aerojet Rocketdyne Holdings,...
From
GlobeNewswire News Releases
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
April 07, 2019
Biotech stocks ended higher for the second straight week, with the presentations at the American Association of Cancer Research annual ...
Tags
ADMA
News
Benzinga
From
Benzinga
Sum Up The Pieces: IBB Could Be Worth $142
April 03, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Eiger BioPharmaceuticals to Participate in Conferences in April
March 26, 2019
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that management will...
From
PR Newswire
Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study Results of Avexitide in Post-Bariatric Hypoglycemia at Endocrine Society Meeting (ENDO) 2019
March 25, 2019
- Statistically Significant Reduction in Hyperinsulinemic Hypoglycemia
From
PR Newswire
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
March 23, 2019
Biotech stocks came under pressure lastweekdespite two FDA approvals coming through. The FDA approved SAGE Therapeutics Inc ...
Tags
FGEN
KLDO
CYCC
From
Benzinga
Eiger BioPharmaceuticals Management Team to Present and Participate in China Healthcare Investment Conference 2019
March 20, 2019
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that David Cory,...
From
PR Newswire
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
March 14, 2019
- Began 2019 with $100.4 million in cash, cash equivalents & short-term investments
From
PR Newswire
Eiger Late-Breaker Oral Presentation of Peginterferon Lambda Phase 2 LIMT Study at The International Liver Congress™ 2019
March 13, 2019
- 36% Durable Virologic Response at 24 Weeks Post-Treatment
From
PR Newswire
Eiger BioPharmaceuticals Management Team to Present and Participate in Jefferies HBV Investor Summit
March 11, 2019
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that David Cory, President...
From
PR Newswire
Clinigen and Eiger BioPharmaceuticals Launch Worldwide Managed Access Program for Lonafarnib for Patients with Progeria and Progeroid Laminopathies
March 03, 2019
Clinigen Group plc (AIM:CLIN, ‘Clinigen’), the global pharmaceutical and services company, has partnered with Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR, ‘Eiger’) to launch a worldwide lonafarnib...
From
Business Wire News Releases
Eiger BioPharmaceuticals Announces the Appointment of Stephana Patton as General Counsel, Corporate Secretary, and Chief Compliance Officer
February 27, 2019
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced the appointment of Dr....
From
PR Newswire
Add Up The Parts: IBB Could Be Worth $145
February 06, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Eiger BioPharmaceuticals Announces Patent Protection for Lonafarnib Boosted with Ritonavir for Treatment of Hepatitis Delta Virus Infection in Europe and Japan
February 06, 2019
Expanded Patent Portfolio Now Includes U.S., Europe and Japan
From
PR Newswire
Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study of Avexitide in Post-Bariatric Hypoglycemia (PBH) at Upcoming Endocrine Society (ENDO) Meeting 2019 in New Orleans
February 04, 2019
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for rare diseases, today announced an oral presentation has been granted for...
From
PR Newswire
EIGR Crosses Above Key Moving Average Level
January 07, 2019
In trading on Monday, shares of Eiger BioPharmaceuticals Inc (EIGR) crossed above their 200 day moving average of $11.28, changing hands as high as $12.07 per share. Eiger BioPharmaceuticals Inc shares...
Tags
Stocks
From
Market News Video
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.